Table 3.
Researches on AKI of TBAD patients.
| Present study | Study 1 | Study 2 | Study 3 | |
|---|---|---|---|---|
| First author, year of publication | Takahashi, 2014 | Ren, 2015 | Luo, 2017 | |
| Total number of patients | 256 | 56 | 76 | 305 |
| Renal artery involvement, n (%) | 256 (100) | 40 (71.4) | NR | NR |
| Age, years (mean) | 53 | 64 | 51 | 55 |
| Treatment | TEVAR | Medical therapy | TEAVR | TEAVR |
| Open surgery, n (%) | No | No | No | A part of (12.5) |
| AKI criteria | KDIGO | AKIN | KDIGO | KDIGO |
| Incidence of AKI (%) | 18 | 36 | 36.8 | 27.5 |
| CTA-based typing | Yes | Yes | Yes | Yes |
| Risk factors | eGFR on admission; | SCr on admission; | SBP on admission; | SBP on admission; |
| Hypertension; | ||||
| The youth (age ≤40 years); DBP on admission; FBG on admission |
ST-T changes on ECG; Narrowing or occlusion of one or both renal arteries |
Stenosis or thrombosis of bilateral renal arteries | Supra-aortic branches graft bypass hybrid surgery |
AKI: acute kidney injury; AKIN: AKI Network; CTA: computed tomography angiography; DBP: diastolic blood pressure; eGFR: estimated glomerular filtration rate; FBG: fasting blood glucose; FL: false lumen; KDIGO: Kidney Disease Improving Global Outcomes; NR: not report; SBP: systolic blood pressure; SCr: serum creatinine; TBAD: type B aortic dissection; TEVAR: thoracic endovascular aortic repair.